Troponins in heart failure.

Area of Science:

• Cardiology
• Biomarkers
• Heart Failure Research

Background:

• Heart failure signs and symptoms are often nonspecific and correlate poorly with objective cardiac function assessments.
• Existing diagnostic tools like echocardiography have limitations in reflecting symptomatic status and functional capacity.
• There is a critical need for reliable circulating biomarkers to enhance heart failure diagnosis and prognosis.

Purpose of the Study:

• To review the clinical performance and utility of cardiac troponin measurements in heart failure.
• To evaluate cardiac troponins as diagnostic and prognostic tools in symptomatic and asymptomatic left ventricular dysfunction.
• To assess the role of cardiac troponins in high-risk phenotypes for developing heart failure.

Main Methods:

• Review of current literature on cardiac troponin I and T assays.
• Analysis of high-sensitivity assays for detecting low circulating concentrations of cardiac troponins.
• Evaluation of diagnostic and prognostic information provided by troponin measurements in various cardiac conditions.

Main Results:

• High-sensitivity cardiac troponin assays improve diagnostic accuracy in acute coronary syndromes.
• Cardiac troponins are frequently detected in chronic circulation across diverse cardiac and non-cardiac diseases, including heart failure.
• Cardiac troponin I and T provide valuable prognostic information for future heart failure development and adverse events in established heart failure.

Conclusions:

• Cardiac troponins are emerging as crucial biomarkers in heart failure management.
• Troponin measurements offer incremental diagnostic and prognostic value beyond traditional assessments.
• These biomarkers are useful in asymptomatic individuals with left ventricular dysfunction and those at high risk for heart failure.